Investing Profile

Guido Magni

InvestorVC
Partner ,Versant Ventures at Versant Ventures
Photo of Guido Magni, Partner at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Alex & Thiago Network
499 CONNECTIONS
Alex & Thiago Network
499 CONNECTIONS
Roche Network
47 CONNECTIONS
Versant Ventures Network
27 CONNECTIONS
Università degli Studi di Padova Network
11 CONNECTIONS
cb
$100K - $5.0M
$1.5M
7
$102.2M
CompanyStageDateRound SizeTotal Raised
Nouscom
Series CNov 2023$73M
Series BNov 2017$49M
Series AMay 2016$14M
$140M
Co-investors: Scott Rocklage (5am Ventures), Sofia Ioannidou (Andera Partners), Joachim Rothe (LSP), Genghis Lloyd-Harris (Abingworth), Hakan Goker (MDC Ventures (formerly KBS Ventures))
Lava Therapeutics
Series CSep 2020$83M
Series AMay 2018$19M
$100M
Co-investors: Nanna Luneborg (Forbion), Laia Crespo (Sanofi Ventures), Joël Jean-Mairet (Ysios Capital)
Aprea
Series BMar 2016$51M
$51M
Co-investors: Scott Rocklage (5am Ventures)
GenSight Biologics
Series AApr 2013$42M
$78M
Co-investors: Genghis Lloyd-Harris (Abingworth)
head of medical science WW, global drug development RochePresent
Chief Medical Officer Alex & ThiagoPresent
Partner ,Versant Ventures Versant VenturesPresent
Co-Founder Alex & ThiagoPresent
Università degli Studi di Padova M.D.; Ph.D. medicine,neuropharmacology
Sign in with Google →
Sign in with Google →